Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microcap Kitchen Canadian Stocks -- Ignore unavailable to you. Want to Upgrade?

To: ayeyou who wrote (24596)	6/1/2014 10:15:26 PM
From: tradeinknow	1 Recommendation Recommended By stonecrop Read Replies (1) \| Respond to of 49402

All im saying is let numbers be the reason.. men lie women lie.. numbers dont.. ANY company that is not profitable is pure speculation and ALL MICROCAP good investors dont buy. Yet they make hundreds of thousands REGULARILY.. im just saying real money is speculation through actual positive numbers. Usually that have had time behind them with no nonsense irregularity. the rest is faith in that the actual good company keeps doin what has made it what ot is.. I dont have faith unless numbers give a reason... Also.. I never said any company in particular.. just saying lets post accordingly so one new or older can look to see progress and gain good habit.. a negative cashflow in any last 4 quarters...negative income... no real rev trend.. just things like those are trades.. not growth. But I hope people make money if they know how to. As retail investors. more than not, like 95 percent or more of the time.. Real money is only made when NUMBERS attract big players..and there is a much much much much much much much much better chance when positive cash..positive income.. An undeniable TREND no matter the size is much harder to do because we want somthing to appear everyday and we can manifest somthing that may take time to form. Money can still be made no doubt and thats good. Chances to make beer money for a year in one trade can def happen everyday.. chances to make real money with limited capital risk and those cxr type moves are much harder. MUCH HARDER. Cxrs move is nice. Hope it stays up for whoever is in it and is profitable the 6 month trend since it has been listed 6 months ago is really somthing. But as I have seen heard read..BELIEVE, time crushes bad company's and helps great ones. I hope everyone makes money.. but as we draw new people to the site.. lets make good habit right off the bat for them as well as ourselves. . Do what u want with your money people. I am pretty sure I have a good case concerning this.

To: ayeyou who wrote (24596)	6/1/2014 10:53:28 PM
From: ogi	1 Recommendation Recommended By stonecrop Read Replies (1) \| Respond to of 49402

Photofrin brought to commercialization by Canadian Co. QLT with cancer applications, bladder cancer being one of them but main thrust was Macular degeneration in the eye, that was 1989-1995. Not up to speed on all the company changes since then.QLT Was a market darling for quite a while. At that time laser light could only penetrate 1 cm, limiting the possible response to the PDC drug by depth of target. The new TLT therapeutic laser has achieved 10 CM Light penetration and recent results indicate their PDC is far more active than the current FDA approved PDCs Theralase PDC was found to be 668,000 times more effective than ALA and 198 times more effective than Photofrin, two currently approved FDA photoactive drugs." After 25 years it makes sense that we may be seeing progress in the development of PDCs

To: ayeyou who wrote (24596)	6/2/2014 12:23:18 AM
From: JoJoK	Read Replies (1) \| Respond to of 49402

This is a more speculative-type investment, which is why some of us are skeptical. Personally, I am skeptical when I'm shown "the next big thing." One problem is that most of us are not experts on the science. I'm not going to read an article then fool myself into thinking I'm an expert. What is the probability of success? How much value can this generate for shareholders? ONTY was 'supposed' to be big. It was a high-rated idea on VIC and the analysis seemed thorough. That idea ended up not working. At least with the other top picks here, we have a good idea of their value and enough information to go on to give us a good level of confidence.

To: ayeyou who wrote (24596)	6/2/2014 10:59:09 AM
From: zen_lunatic420	Read Replies (1) \| Respond to of 49402

MBX: Microbix is now profitable in their core business of providing infectious disease antigens, most notably for the increasing demand for Dengue Fever test kits, as major pharma companies work towards developing an effective vaccine as well. Also, Microbix pipeline of products is much closer to the market than a drug candidate in preclinical testing. Lumisort won't require a FDA drug approval, Virusmax lawsuit is a year or two away from trial, but an interested licensee could likely begin using the technology with a relatively simple modification to an existing approval, and their Urokinase is already FDA approved, they would just need the FDA to approve the new manufacturing plant, if and/or when they find a partner. I have no qualm with you discussing TLT here, but think that off-base analogy was perhaps a bit off base itself. Good luck, I do find it interesting and will put it on my watchlist.